|
|
 |
Welcome to the Investor Relations Area of
aap Implantate AG |
|
aap Implantate AG has been listed on the stock exchange since May 10, 1999. With the closure of the Neuer Markt, the aap Implantate AG stock is listed since May 16, 2003 in the Prime Standard segment of the German stock exchange, a segment of the regulated market with more extensive post-admission requirements.
|
|
| Company | aap Implantate AG | | International Securities Identification Number (ISIN) | DE 0005066609 | | SIN (WKN) | 506 660 | | Listing | All German Stock Exchanges, XETRA | | Stock Symbol | AAQ | | Market Segment | Prime Standard (since May 16, 2003) Neuer Markt (till May 15, 2003) | | Indices | CDAX Prime All Share Index Technology All Share Index | | Prime Sector | Pharma & Healthcare | | Industry Group | Medical Technology | | Capital Stock | EUR 30,670,056 | | Number of Bearer Shares | 30,670,056 | | Authorized Capital | EUR 30,670,056 | | Designated Sponsor | DZ Bank AG |
|
|
|
|
|
|
|
|
News
|
|
aap reports profitable Q1 2012 sales growth of 51% to EUR 9.9 million; Increased sales forecast for the financial year 2012 to EUR 34 million (+16%)
|
|
aap: 51% sales increase to EUR 9.8 million in the first quarter 2012
|
|
|
|
Next Upcoming Events
|
|
July 6, 2012
Annual General Meeting in Berlin
|
|
August 14, 2012
Publication of second quarterly report 2012
|
|
|
|
|
|
Print this page
